Clinical Trial Details

Trial ID: L0873
Source ID: IRCT201506222480N6
Associated Drug: Genistein
Title: The effect of genistein supplementation on glycemic state, insulin resistance and adipose tissue in non alcoholic fatty liver patients
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: non alcoholic fatty liver. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
Interventions: Intervention 1: wheat starch in capsule once a day for 8 weeks. Intervention 2: 250 mg genistein as capsule once per day for 8 weeks.;Placebo;Treatment - Drugs;wheat starch in capsule once a day for 8 weeks;250 mg genistein as capsule once per day for 8 w
Outcome Measures: Insulin. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;FBS. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;Fat mass. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By BIA device.HOMA-IR. Timepoint: Before and two months after intervention inception. Method of measurement: Calculate by HOMA index equation.
Sponsor/Collaborators: Shiraz University of Medical Sciences
Gender: All
Age: 18 years70 years
Phases: Phase 3
Enrollment: 100
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
Start Date: 12/07/2015
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/2210